Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (9) , 1112-1118
Abstract
No abstract availableKeywords
Funding Information
- Tehran University of Medical Sciences and Health Services (26179)
This publication has 36 references indexed in Scilit:
- Extended immunologic and genetic lineage of mammary analogue secretory carcinoma of salivary glandsHuman Pathology, 2016
- ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic TumorsAmerican Journal of Surgical Pathology, 2016
- Transcriptome sequencing identifies ETV6–NTRK3 as a gene fusion involved in GISTThe Journal of Pathology, 2015
- ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancerCancer, 2013
- Mammary analog secretory carcinoma of salivary glands: A report of 2 cases with expression of basal/myoepithelial markers (calponin, CD10 and p63 protein)Pathology - Research and Practice, 2013
- Mammary Analog Secretory Carcinoma of Salivary Gland Origin With the ETV6 Gene Rearrangement by FISHAmerican Journal of Surgical Pathology, 2012
- Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor EntityAmerican Journal of Surgical Pathology, 2010
- ETV6–NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineagesSeminars in Cancer Biology, 2005
- Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinomaCancer Cell, 2002
- Fusion of ETV6 to Neurotrophin-3 Receptor TRKC in Acute Myeloid Leukemia With t(12;15)(p13;q25)Blood, 1999